Hypertension Trial, Recruiting NCT07683585 Sponsor: National Medical Research Center for Therapy and Preventive Medicine Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT07683585
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 50 and 70 years old
  • People who have been diagnosed with high blood pressure
  • People who have been diagnosed with coronary artery disease (a condition where the arteries supplying the heart become narrowed)
  • People who are admitted to hospital for a planned, non-emergency procedure to open blocked or narrowed heart arteries
  • People who have had a stent (a small tube that holds an artery open) placed in a heart artery during this hospital stay
  • People whose blood pressure requires two medications to control it
  • People already being treated with beta-blockers (a type of heart/blood pressure medication), cholesterol-lowering medication, and blood-thinning medication
  • People who are able and willing to sign a written consent form agreeing to take part

Who may not be able to join:

  • People who are unable or unwilling to sign a consent form
  • People who are having a heart attack or experiencing an acute (sudden, severe) heart event at the time of enrolment
  • People with an active cancer diagnosis
  • People who have had a blood clot in the lungs (pulmonary embolism)
  • People with advanced chronic kidney disease (stage 4 or 5)
  • People diagnosed with type 2 diabetes
  • People who cannot safely take the study medications — for example, those with narrowing of both kidney arteries, high potassium levels in the blood, high uric acid levels, or gout
  • Women who are of reproductive age (confirm with trial site for exact definition)
  • People with a permanent or long-lasting irregular heart rhythm called atrial fibrillation
  • People who have another planned stent procedure scheduled after this one (staged stenting)
  • People with heart failure where the heart's pumping function is significantly reduced
  • People with any other health condition that, in the opinion of the research team, could affect their ability to participate or affect the reliability of the study results

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Olga Dzhioeva, National Medical Research Center for Therapy and Preventive Medicine

Phone: +7 (937) 104-73-31

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National Medical Research Center for Therapy and Preventive Medicine
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
1 July 2026

Where this trial is recruiting

🇷🇺 Russia

Primary endpoints

Change in office systolic and diastolic blood pressure (mmHg)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov